[{"Assets_0_FY_USD":118132000.0,"CommonStockSharesOutstanding_0_FY_shares":17277750.0,"NetCashProvidedByUsedInOperatingActivities_4_FY_USD":-36365000.0,"NetIncomeLoss_1_FY_USD":-8526000.0,"NetIncomeLoss_4_FY_USD":-20816000.0,"StockholdersEquity_0_FY_USD":96738000.0,"Assets_0_Q1_USD":119884000.0,"CommonStockSharesOutstanding_0_Q1_shares":17815493.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-11275000.0,"NetIncomeLoss_1_Q1_USD":-7338000.0,"StockholdersEquity_0_Q1_USD":101867000.0,"Ticker":"KALV","CIK":"1348911","name":"KALVISTA PHARMACEUTICALS, INC.","OfficialName":"KalVista Pharmaceuticals Inc. Common Stock","form":"10-K","period":"20190430","fy":"2019.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"339433230.0","Country":"United Kingdom","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20190909"}]